- Acquired by Eli Lilly
- Richard Aldrich, Christoph Westphal
- Cambridge, MA
- Health and Wellness, Biotechnology
- Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company's innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.
Past Team (5)Update
Funding Rounds (2) - $55MUpdate
Healthcare Venture Capital
Bessemer Venture Partners has over 100 years of investing experience, with a portfolio ranging...
Third Rock Ventures invests in transformational life science companies that show high growth...
Founded in 1991, Frazier Healthcare Ventures is one of the leading providers of venture and...
840 Memorial Drive
Cambridge, MA 02139